• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis.

作者信息

Valcarcel Bryan, Schonfeld Sara J, Shiels Meredith S, Castillo Jorge J, Morton Lindsay M

机构信息

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, Bethesda, Maryland.

出版信息

Haematologica. 2025 Mar 1;110(3):799-803. doi: 10.3324/haematol.2024.286343.

DOI:10.3324/haematol.2024.286343
PMID:39479866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11873710/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d3/11873710/6e772ad50993/110799.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d3/11873710/e06685560b36/110799.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d3/11873710/6e772ad50993/110799.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d3/11873710/e06685560b36/110799.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39d3/11873710/6e772ad50993/110799.fig2.jpg

相似文献

1
Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis.2001年至2016年美国伴有和不伴有HIV的弥漫性大B细胞淋巴瘤患者的生存结果：一项基于人群的分析。
Haematologica. 2025 Mar 1;110(3):799-803. doi: 10.3324/haematol.2024.286343.
2
Survival in advanced diffuse large B-cell lymphoma in pre- and post-rituximab Eras in the United States.美国利妥昔单抗治疗时代前后弥漫性大 B 细胞淋巴瘤的生存情况。
Anticancer Res. 2014 Sep;34(9):5117-20.
3
HIV-associated splenic diffuse large B-cell lymphoma combined with hepatitis C and tuberculous meningitis:A case report.人类免疫缺陷病毒相关脾弥漫性大B细胞淋巴瘤合并丙型肝炎和结核性脑膜炎：一例报告
Heliyon. 2023 Sep 12;9(9):e20073. doi: 10.1016/j.heliyon.2023.e20073. eCollection 2023 Sep.
4
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.硼替佐米联合标准化疗免疫治疗弥漫性大 B 细胞淋巴瘤（REMoDL-B）的基因表达谱分析：一项开放标签、随机、3 期临床试验。
Lancet Oncol. 2019 May;20(5):649-662. doi: 10.1016/S1470-2045(18)30935-5. Epub 2019 Apr 1.
5
Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance.澳大利亚治疗人类免疫缺陷病毒相关性伯基特淋巴瘤和弥漫性大 B 细胞淋巴瘤的结果：来自澳大利亚淋巴瘤联盟的报告。
Br J Haematol. 2023 Jun;201(5):865-873. doi: 10.1111/bjh.18704. Epub 2023 Mar 3.
6
Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression.北美的弥漫性大 B 细胞淋巴瘤患者的预后与肿瘤的 Epstein-Barr 病毒阳性或免疫抑制无关。
Haematologica. 2018 Feb;103(2):297-303. doi: 10.3324/haematol.2017.176511. Epub 2017 Nov 23.
7
Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein-Barr virus infection and survival.在 HIV 高发的南非队列中弥漫性大 B 细胞淋巴瘤：基于细胞起源、EB 病毒感染和生存的分析。
Pathology. 2020 Jun;52(4):453-459. doi: 10.1016/j.pathol.2020.02.007. Epub 2020 Apr 15.
8
Survival of patients with gastric lymphoma in Germany and in the United States.德国和美国胃淋巴瘤患者的生存率。
J Gastroenterol Hepatol. 2015 Oct;30(10):1485-91. doi: 10.1111/jgh.12989.
9
Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study).初始化疗周期和临床特征对 HIV 相关弥漫性大 B 细胞淋巴瘤患者结局的影响：中国中西部地区 AIDS 相关淋巴瘤联盟 001 研究（CALL-001 研究）。
Front Immunol. 2023 Mar 29;14:1153790. doi: 10.3389/fimmu.2023.1153790. eCollection 2023.
10
Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma.含蒽环类化疗药物对美国80岁及以上弥漫性大B细胞淋巴瘤退伍军人的相对疗效。
J Geriatr Oncol. 2015 May;6(3):211-8. doi: 10.1016/j.jgo.2015.01.003. Epub 2015 Jan 19.

引用本文的文献

1
A national, multicenter, retrospective study of human immunodeficiency virus infection-associated lymphoma in China.一项关于中国人类免疫缺陷病毒感染相关淋巴瘤的全国性、多中心回顾性研究。
Clin Exp Med. 2025 Aug 11;25(1):285. doi: 10.1007/s10238-025-01827-4.
2
[How I treat lymphomas associated with HIV infection].[我如何治疗与HIV感染相关的淋巴瘤]
Zhonghua Xue Ye Xue Za Zhi. 2025 Feb 14;46(2):120-125. doi: 10.3760/cma.j.cn121090-20241108-00441.

本文引用的文献

1
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey.采用美国德尔菲法调查，改善弥漫性大 B 细胞淋巴瘤患者一线试验的入选标准。
Blood Adv. 2022 May 10;6(9):2745-2756. doi: 10.1182/bloodadvances.2021006504.
2
Hematologic cancers in individuals infected by HIV.感染HIV的个体中的血液系统癌症。
Blood. 2022 Feb 17;139(7):995-1012. doi: 10.1182/blood.2020005469.
3
Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.美国的 HIV 流行病学：流行负担、不平等、背景和应对措施。
Lancet. 2021 Mar 20;397(10279):1095-1106. doi: 10.1016/S0140-6736(21)00395-0. Epub 2021 Feb 19.
4
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals.基于人群的 HIV 感染者和免疫功能正常个体弥漫性大 B 细胞淋巴瘤的结局分析。
Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.
5
Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective.青少年及年轻成人侵袭性 B 细胞 NHL 的治疗：成人与儿科视角。
Blood. 2018 Jul 26;132(4):369-375. doi: 10.1182/blood-2018-02-778480. Epub 2018 Jun 12.
6
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.在现代联合抗逆转录病毒治疗时代，艾滋病毒相关弥漫性大 B 细胞淋巴瘤的结局。
AIDS. 2017 Nov 28;31(18):2493-2501. doi: 10.1097/QAD.0000000000001652.
7
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.1996 年至 2012 年美国 HIV 感染者的癌症风险：基于人群的登记关联研究。
Lancet HIV. 2017 Nov;4(11):e495-e504. doi: 10.1016/S2352-3018(17)30125-X. Epub 2017 Aug 10.
8
HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy.高效抗逆转录病毒治疗时代的HIV感染与淋巴瘤患者的生存情况
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):303-311. doi: 10.1158/1055-9965.EPI-16-0595. Epub 2016 Oct 18.
9
Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.抗逆转录病毒治疗时代与人类免疫缺陷病毒相关的淋巴瘤：国家癌症数据库分析。
Cancer. 2016 Sep 1;122(17):2689-97. doi: 10.1002/cncr.30112. Epub 2016 Jun 23.
10
The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.三十年抗逆转录病毒疗法的演进：挑战、成就与未来的前景
Br J Clin Pharmacol. 2015 Feb;79(2):182-94. doi: 10.1111/bcp.12403.